Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 3/20 | 0.40 |
| ▸ | TACR2 | P21452 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | BRS3 | P32247 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9027834 | 0.95 | TACR1 (0.39) | TACR1TACR2HRH1BRS3KDM4E | |
| SCHEMBL9027964 | 0.93 | TACR1 (0.40) | TACR1TACR2HRH1 | |
| SCHEMBL9027873 | 0.90 | TACR1 (0.41) | TACR1TACR2HRH1 | |
| SCHEMBL9028446 | 0.89 | TACR1 (0.42) | TACR1TACR2HRH1 | |
| SCHEMBL9027525 | 0.89 | TACR1 (0.43) | TACR1TACR2HRH1KDM4EALDH1A1 | |
| SCHEMBL9026973 | 0.89 | TACR1 (0.41) | TACR1TACR2HRH1 | |
| SCHEMBL9027626 | 0.89 | TACR1 (0.51) | TACR1TACR2 | |
| SCHEMBL9027398 | 0.88 | TACR1 (0.47) | TACR1TACR2HRH1ALDH1A1 | |
| SCHEMBL9028004 | 0.88 | TACR1 (0.43) | TACR1TACR2HRH1KDM4EALDH1A1 | |
| SCHEMBL9028989 | 0.87 | TACR1 (0.43) | TACR1TACR2HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5563133-A | NERVOUS SYSTEM DISORDERS | ELI LILLY AND COMPANY (US) | 1996-10-08 | — | — | US | disclosed |
| EP-0714891-A1 | Heterocyclic tachykinin receptor antagonists | ELI LILLY AND COMPANY (US) | 1996-06-05 | — | — | EP | disclosed |